Form 8-K - Current report:
SEC Accession No. 0001628280-18-005830
Filing Date
2018-05-03
Accepted
2018-05-03 16:07:19
Documents
2
Period of Report
2018-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adms8-kq12018.htm 8-K 29918
2 EXHIBIT 99.1 adms991erq12018.htm EX-99.1 57811
  Complete submission text file 0001628280-18-005830.txt   88949
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 18803788
SIC: 2834 Pharmaceutical Preparations